Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis.

ABSTRACT:

Objectives

To evaluate the cost-effectiveness of the 9-valent human papillomavirus (HPV) vaccine for the prevention of cervical cancer in China.

Design

Health economic modelling using the Papillomavirus Rapid Interface for Modelling and Economics (PRIME) model populated with China-specific data.

Setting

Individual cervical cancer prevention in China using the 9-valent HPV vaccine from the perspective of private sector purchasers in relation to receiving other HPV vaccines and not receiving vaccination for 16-year-old girls in China who had not been previously infected with HPV.

Participants

Not applicable.

Interventions

Vaccination using the 9-valent, the quadrivalent and the bivalent vaccines.

Primary outcome measure

Incremental costs per disabil

SUBMITTER: Jiang Y 

PROVIDER: S-EPMC6886925 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature